IRIS
CUDILLO, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.968
EU - Europa 1.974
AS - Asia 530
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 25.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.957
DE - Germania 607
UA - Ucraina 343
CN - Cina 330
IT - Italia 246
IE - Irlanda 227
GB - Regno Unito 138
KR - Corea 130
SE - Svezia 114
FR - Francia 88
RU - Federazione Russa 66
FI - Finlandia 65
PL - Polonia 44
BE - Belgio 15
UZ - Uzbekistan 14
HK - Hong Kong 11
KG - Kirghizistan 10
CA - Canada 7
IN - India 7
JP - Giappone 7
BR - Brasile 5
IR - Iran 5
AT - Austria 4
CL - Cile 4
ES - Italia 4
EU - Europa 4
CH - Svizzera 3
GR - Grecia 3
MX - Messico 3
PE - Perù 3
RO - Romania 3
SG - Singapore 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
IL - Israele 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
KW - Kuwait 1
NL - Olanda 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
Totale 25.494
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.016
Wilmington 6.287
Houston 5.656
Ann Arbor 646
Fairfield 600
Chandler 445
Ashburn 351
Jacksonville 294
Seattle 282
Dublin 220
Cambridge 217
Medford 169
Dearborn 120
Beijing 114
New York 107
Rome 93
Zhengzhou 81
Lawrence 80
Kraków 42
San Diego 35
Menlo Park 32
Mülheim 30
Milan 23
Falls Church 21
Norwalk 18
Shanghai 16
Brussels 15
Hefei 15
Kunming 13
London 13
Bologna 12
University Park 12
Nanjing 11
Rieti 11
Hong Kong 10
Mountain View 10
San Mateo 10
Nürnberg 9
Palo Alto 9
Saint Petersburg 9
Boardman 8
Redmond 8
Redwood City 8
San Francisco 8
Verona 8
Guangzhou 7
Nanchang 7
Creede 6
Hounslow 6
Los Angeles 6
Auburn Hills 5
Chengdu 5
Helsinki 5
Santa Clara 5
Acton 4
Changsha 4
Chongqing 4
Fuzhou 4
Hebei 4
Jinan 4
Shenyang 4
Toronto 4
Colorado Springs 3
Detroit 3
Hangzhou 3
Hanoi 3
Indiana 3
Latina 3
Lima 3
Madrid 3
Pars 3
Phoenix 3
Seoul 3
São Paulo 3
Washington 3
Anzio 2
Baotou 2
Bellingham 2
Bussero 2
Canberra 2
Center 2
Chiswick 2
Donetsk 2
Duncan 2
Hanawada 2
Mexico 2
Minatomirai 2
Nauka 2
Nea Smyrni 2
Porto Torres 2
Riyadh 2
Roebling 2
San Jose 2
Shaoxing 2
Southwark 2
Vienna 2
Viterbo 2
Warsaw 2
Wuhan 2
Xian 2
Totale 23.367
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 487
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 477
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 471
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 450
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 437
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 429
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 426
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 426
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 424
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patients 419
Aspergillus niger infection in patients with haematological diseases: a report of eight cases 418
Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options 408
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 404
The therapeutic use of cord blood 404
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 399
Localization of aspergillosis to the central nervous system among patients with acute leukemia: Report of 14 cases 396
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 392
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 390
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 389
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 383
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 383
aplastic anemia and viral hepatitis 382
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 381
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 378
Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies 377
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 376
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 372
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 372
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 371
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. 369
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. 368
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 367
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 366
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 366
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 362
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 361
Aplastica Anemia and Viral Hepatitis 361
Epidemiology of invasive fungal diseases in haematopoietic stem cell transplant recipients: preliminary analysis of a multicentre, prospective, observational study from Italy 359
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 355
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 353
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 348
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO 346
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 346
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 345
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 345
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 339
Peripheral polyneuropathy during treatment with alpha-2 interferon 336
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 331
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 329
Bone marrow processing with a gravity sedimentation technique: experience of 13 cases 325
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 324
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 319
Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report. 317
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 314
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 308
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 307
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 306
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 304
Il Trapianto di Cellule Stminali Emopoietiche. 297
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 295
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 281
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 273
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 273
Epidemiological survey on severe infectious diseases 261
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 255
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 254
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 237
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 151
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 135
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 131
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network 123
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 120
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 119
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 117
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 116
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 116
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network 113
Platelet-rich plasma as treatment for persistent ocular epithelial defects 106
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 105
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 100
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience 11
Totale 25.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.081 0 0 0 0 0 0 0 0 0 760 710 611
2019/20206.679 572 547 478 566 541 705 601 539 535 617 503 475
2020/20214.042 459 465 458 549 360 448 503 372 109 110 177 32
2021/2022803 27 105 43 47 26 74 39 45 48 59 48 242
2022/20231.122 118 108 48 161 77 241 85 62 122 13 64 23
2023/2024291 45 14 19 11 39 125 17 8 11 2 0 0
Totale 25.686